Page 6,119«..1020..6,1186,1196,1206,121..6,1306,140..»

Can acupuncture ease Parkinson's symptoms?

Posted: Published on November 20th, 2012

When Michael J. Fox got an ovation at this year's Emmys, it highlighted how much he's done to help people understand Parkinson's disease and to demonstrate how to live with it. His latest show (on air in 2013) echoes his real-life story: It's a comedy about a father of three who has Parkinson's. More than a million North Americans also have the neurological disease (it disrupts production of the neurotransmitter dopamine, which can affect movement, balance, thinking and emotions). It can take 20 years for the characteristic spasms and twitches to develop. The first signs -- often ignored -- include loss of sense of smell and jerky movements during deep sleep. The latest theory about the cause: a virus that enters the body through the nose or gut. Contaminated, illicit designer drugs also have been known to trigger the disorder. While there is no cure as of now, some alternative therapies (used along with conventional medications) seem to ease symptoms. The latest news is that acupuncture, when used on a specific point (GB34) on the outside of the right leg below the knee, reactivates, at least temporarily, an area of the brain that is knocked offline by Parkinson's. So far, … Continue reading

Posted in Parkinson's Treatment | Comments Off on Can acupuncture ease Parkinson's symptoms?

Amarantus BioSciences Issues CEO Letter to Shareholders

Posted: Published on November 20th, 2012

SUNNYVALE, Calif., Nov. 19, 2012 /PRNewswire/ --Amarantus BioSciences, Inc. (AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that President & CEO Gerald Commissiong issued a letter to shareholders as detailed below. Dear Shareholders, I thank you for the trust you have placed in our management team. We fully respect the value of the money you have chosen to invest in Amarantus Biosciences, selecting us over the many other investment options available. We are focused on our mission to offer meaningful products to help patients suffering from debilitating diseases, and we believe our technologies and expertise can have an impact in multiple areas. As was recently announced, we were able to strengthen the corporation's balance sheet by raising cash and reducing liabilities. These financing transactions were vital for the Company to pay certain vendors who are critical to on-going operations, as well as raise sufficient working capital to pursue our corporate strategy, as detailed below. Our management team and Board of Directors remain extremely dedicated to the overall success of the corporation. This is evidenced by every member working without cash consideration since … Continue reading

Posted in Parkinson's Treatment | Comments Off on Amarantus BioSciences Issues CEO Letter to Shareholders

Potential cause of Parkinson's disease identified

Posted: Published on November 20th, 2012

ScienceDaily (Nov. 19, 2012) Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease. The discovery could lead to new targets for Parkinson's that may be useful in preventing the actual condition. The team, led by TSRI neuroscientist Bruno Conti, describes the work in a paper published online ahead of print on November 19, 2012 by the Journal of Immunology. Parkinson's disease plagues about one percent of people over 60 years old, as well as some younger patients. The disease is characterized by the loss of dopamine-producing neurons primarily in the substantia nigra pars compacta, a region of the brain regulating movements and coordination. Among the known causes of Parkinson's disease are several genes and some toxins. However, the majority of Parkinson's disease cases remain of unknown origin, leading researchers to believe the disease may result from a combination of genetics and environmental factors. Neuroinflammation and its mediators have recently been proposed to contribute to neuronal loss in Parkinson's, but how these factors could … Continue reading

Posted in Parkinson's Treatment | Comments Off on Potential cause of Parkinson's disease identified

The little boy suffering from cerebral palsy who hopes to walk in time for Christmas – thanks to Botox jabs in his legs

Posted: Published on November 20th, 2012

Botox relaxes the contraction of muscles in some people with cerebral palsy by blocking nerve impulses Aiden will have the treatment in December followed by a course of intensive physiotherapy By Anna Hodgekiss PUBLISHED: 11:32 EST, 19 November 2012 | UPDATED: 11:32 EST, 19 November 2012 The parents of a three-year-old boy with cerebral palsy hope he will be walking by Christmas, after doctors said Botox could help relax the muscles in his legs. Aiden Farrell was diagnosed with the condition after he was born prematurely at 29 weeks. Over the years his leg muscles have tightened to the extent that he can no longer walk. Doctors told Aiden's parents Sara and Gevun Farrell, that the wrinkle-buster could help but there was a 12-month waiting list on the NHS. Aiden Farrell will have the life-changing treatment to relax the over-active muscles in his legs The couple from Gosport, Hampshire, began fundraising to help pay for private Botox treatment. Local residents helped raise 7,000 to pay for the treatment. But after the three-year-olds condition worsened last month, the NHS will now carry out the treatment on December 14. The money raised will now be spent on intensive physiotherapy for Aiden at … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on The little boy suffering from cerebral palsy who hopes to walk in time for Christmas – thanks to Botox jabs in his legs

NeuroVive and Sihuan Pharmaceutical to Develop and Commercialise CicloMulsion® and NeuroSTAT® for Cardio- and …

Posted: Published on November 20th, 2012

BEIJING and LUND, Sweden, November 20, 2012 /PRNewswire/ -- NeuroVive, the leading mitochondrial medicine company, today announces a collaboration agreement with Sihuan Pharmaceutical Holdings Group Ltd. for the development and commercialisation in China of NeuroVive's most clinically advanced products CicloMulsion and NeuroSTAT. Sihuan Pharmaceutical is one of the largest domestic pharmaceutical companies in China and the market leader in the fast-growing Chinese cardio-cerebral vascular (CCV) drugs market. The agreement was entered into by Sihuan Pharmaceutical through its wholly-owned subsidiary Sun Moral International (HK) Ltd. and by NeuroVive through its subsidiary NeuroVive Pharmaceutical Asia Ltd. CicloMulsion and NeuroSTAT are in clinical development by NeuroVive for the treatment of heart reperfusion injury after stenting and traumatic brain injury respectively. These are indications of huge medical need for which there are currently no approved pharmaceutical treatment options. Both products act to prevent the death of mitochondria in damaged cells and the cascade of intracellular biochemical events that lead to secondary tissue damage following a traumatic injury. By protecting a cell's mitochondria NeuroVive's products ensure that energy production is preserved and a damaged cell's normal regenerative mechanisms can act to repair and maintain the cell. CicloMulsion and NeuroSTAT contain cyclosporine which, by inhibiting cyclophilin … Continue reading

Posted in Brain Injury Treatment | Comments Off on NeuroVive and Sihuan Pharmaceutical to Develop and Commercialise CicloMulsion® and NeuroSTAT® for Cardio- and …

Banasiewicz leaves traumatic brain injury rehab

Posted: Published on November 20th, 2012

Updated: November 18, 2012, 3:28 PM ET Bare Essentials Sports MedicineBrett Banasiewicz at the Shepherd Center in Atlanta, Ga. earlier this week. On September 24, DK Bicycles BMX pro Brett Banasiewicz was transported to the Shepherd Center in Atlanta, Ga. to begin rehabilitation on a traumatic brain injury suffered on August 23 in Virginia Beach, Va. Banasiewicz was transported to Atlanta via MedJet medical transport, and entered the Shepherd Center on a stretcher. Yesterday morning, he walked out of the facility on his own. Banasiewicz, 18, will remain in the Atlanta area for several days to finish up treatment in a hyperbaric chamber before returning home to South Bend, Ind. for the Thanksgiving holiday. After some time at home with his family, Banasiewicz will travel to Dallas, Texas to begin outpatient therapy. Upon entering the facility in Atlanta, Banasiewicz set three goals for himself: leave the wheelchair, leave the feeding tube behind and get his voice back. He accomplished all three goals, having the feeding tube removed earlier this week, mumbling "I want an iPhone 5" on Friday and walking to the car yesterday. Banasiewicz also regained over twenty pounds in the past two weeks. "See ya later Shepherd Center, … Continue reading

Posted in Brain Injury Treatment | Comments Off on Banasiewicz leaves traumatic brain injury rehab

‘Nanoparticles’ may help scientists develop MS jab

Posted: Published on November 20th, 2012

By John von Radowitz Monday, November 19, 2012 Tiny synthetic particles could help scientists to develop vaccines against immune response diseases such as multiple sclerosis (MS), research has shown. The "nanoparticles" trick the immune system into calming down and behaving normally. In tests on mice, they halted a rodent version of relapsing-remitting MS, the most common form of the autoimmune disease. Scientists believe the technology could be applied to a range of immune system disorders, including type-1 diabetes, food allergies, and asthma. MS occurs when the immune system attacks myelin, the fatty insulation that surrounds nerve fibres. Breaks in the myelin coating prevent nerve messages being transmitted properly, leading to symptoms ranging from numbness and tingling to full-blown paralysis. Current treatments for MS rely on suppressing the immune system, which can make patients susceptible to infections and cancer. Instead, the nanoparticle vaccine re-sets the immune system to stop the "friendly fire" attacks. The nanoparticles, made from two biodegradable compounds that naturally occur in the body, are attached to myelin proteins. The rest is here: ‘Nanoparticles’ may help scientists develop MS jab … Continue reading

Posted in MS Treatment | Comments Off on ‘Nanoparticles’ may help scientists develop MS jab

Multiple Sclerosis Breakthrough: Nanoparticle Halts Disease in Mice

Posted: Published on November 20th, 2012

Jack Osbourne was diagnosed with multiple sclerosis earlier this year after he lost 60 per cent of his vision in his right eye (Reuters) A scientific breakthrough has arrested the development of multiple sclerosis in mice and has implications for a new treatment for the degenerative disease. Researchers at Northwestern University in Illinois found a new nanoparticle that tricks and resets the immune systems of mice with MS. MS is a neurological disease that affects around 100,000 people in the UK. It is mostly diagnosed in people who are aged between 20 and 40. A substance called myelin protects nerve fibres in the central nervous system. When people have MS, their immune system, which would normally fight off infections, mistakes myelin for a foreign body and attacks it. These attacks damage the myelin and strips it of nerve fibres. Over time, this nerve damage causes the accumulation of disability. The new nanoparticle works by delivering an antigen that makes the immune system stop its attack on myelin and halt relapsing remitting MS in mice. Around 80 per cent of people with MS are diagnosed with the relapsing remitting form of the disease. People who suffer from relapsing remitting MS have … Continue reading

Posted in MS Treatment | Comments Off on Multiple Sclerosis Breakthrough: Nanoparticle Halts Disease in Mice

New hope for MS, other autoimmune diseases

Posted: Published on November 20th, 2012

By Maggie Fox, NBC News Researchers trying to find a way to treat multiple sclerosis think theyve come up with an approach that could not only help patients with MS, but those with a range of so-called autoimmune diseases, from type-1 diabetes to psoriasis, and perhaps even food allergies. So far its only worked in mice, but it has worked especially well. And while mice are different from humans in many ways, their immune systems are quite similar. If this works, it is going to be absolutely fantastic, said Bill Heetderks, who directs outside research at the National Institute of Biomedical Imaging and Bioengineering, part of the National Institutes of Health, which helped pay for the research. Even if it doesnt work, its going to be another step down the road. In autoimmune disease, the bodys immune cells mistakenly attack and destroy healthy tissue. In MS, its the fatty protective sheath around the nerves; in type-1 or juvenile diabetes its cells in the pancreas that make insulin; in rheumatoid arthritis its tissue in the joint. Currently, the main treatment is to suppress the immune system, an approach that can leave patients vulnerable to infections and cancer. The new treatment re-educates … Continue reading

Posted in MS Treatment | Comments Off on New hope for MS, other autoimmune diseases

It's a 'Beauty': Nanoparticles Treatment Tricks MS

Posted: Published on November 20th, 2012

Scientists have developed a way of modifying a microscopic particle which could offer a new approach to tackling major diseases such as multiple sclerosis, Type 1 diabetes, asthma and food allergies. Instead of taking a drug that suppresses the entire immune system, making sufferers more susceptible to infections and cancer, patients may in future be given a nanoparticle treatment which can selectively inhibit the part of the immune system responsible for their disease. When primed, the nanoparticle can trick the immune system into halting its attack on the body which is a characteristic of these diseases. Researchers from Northwestern University in the US, funded by the National Institutes for Health, used the technique to block the progression of multiple sclerosis in mice. In MS, the immune system attacks the protective myelin sheath that surrounds the nerve fibres in the brain and spinal cord, causing symptoms ranging from numbness to paralysis. They injected nanoparticles attached to myelin antigens - proteins to stop the immune system from recognising the myelin sheath as an alien invader - which reset the immune system to normal and halted the attack. Stephen Miller , a professor of microbiology and one of the authors of the study, … Continue reading

Posted in MS Treatment | Comments Off on It's a 'Beauty': Nanoparticles Treatment Tricks MS

Page 6,119«..1020..6,1186,1196,1206,121..6,1306,140..»